Summary for ENCSR167QXA
doi:10.17989/ENCSR167QXA
Summary
- Status
- released
- Description
- DNase-seq on H7-hESCs differentiated into cardiovascular cells over 14 days.
- Donor diversity
- single
- Assay
- DNase-seq
- Biosample summary
- cardiovascular progenitor cell in vitro differentiated cells, mesodermal cell in vitro differentiated cells, cardiac myoblast in vitro differentiated cells, cardiac muscle cell in vitro differentiated cells, H7 cell line treated with Fibroblast growth factor 2, Bone morphogenetic protein 4, Activin A
- Diseases
- Not reported
- Treatments
- 10 ng/mL Bone morphogenetic protein 4, 5 ng/mL Fibroblast growth factor 2, 6 ng/mL Activin A
Attribution
ENCODE2 project
- Lab
- John Stamatoyannopoulos, UW
- Award
- U54HG004592 (John Stamatoyannopoulos, UW)
- Project
- ENCODE
- External resources
- None submitted
- References
Experiments in ENCSR167QXA
Experiments
5 experiments
Accession | Duration | Biosample summary | Lab | Status | Cart |
|---|---|---|---|---|---|
| ENCSR000EMZ | Homo sapiens H7 | John Stamatoyannopoulos, UW | released | ||
| ENCSR000EMX | 2 days | Homo sapiens mesodermal cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 2 days, 6 ng/mL Activin A for 2 days, 10 ng/mL Bone morphogenetic protein 4 for 2 days | John Stamatoyannopoulos, UW | released | |
| ENCSR000EMW | 5 days | Homo sapiens cardiovascular progenitor cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 5 days, 10 ng/mL Bone morphogenetic protein 4 for 5 days, 6 ng/mL Activin A for 5 days | John Stamatoyannopoulos, UW | released | |
| ENCSR000EMV | 9 days | Homo sapiens cardiac myoblast originated from H7 treated with 10 ng/mL Bone morphogenetic protein 4 for 9 days, 5 ng/mL Fibroblast growth factor 2 for 9 days, 6 ng/mL Activin A for 9 days | John Stamatoyannopoulos, UW | released | |
| ENCSR000EMY | 14 days | Homo sapiens cardiac muscle cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 14 days, 10 ng/mL Bone morphogenetic protein 4 for 14 days, 6 ng/mL Activin A for 14 days | John Stamatoyannopoulos, UW | released |